173 related articles for article (PubMed ID: 29463227)
21. Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?
Hofvind S; Wang H; Thoresen S
Acta Oncol; 2004; 43(5):467-73. PubMed ID: 15360051
[TBL] [Abstract][Full Text] [Related]
22. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
23. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
24. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.
Hofvind S; Ursin G; Tretli S; Sebuødegård S; Møller B
Cancer; 2013 Sep; 119(17):3106-12. PubMed ID: 23720226
[TBL] [Abstract][Full Text] [Related]
26. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
[TBL] [Abstract][Full Text] [Related]
27. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
[TBL] [Abstract][Full Text] [Related]
28. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
29. Overdiagnosis of breast cancer after 14 years of mammography screening.
Zahl PH; Mæhlen J
Tidsskr Nor Laegeforen; 2012 Feb; 132(4):414-7. PubMed ID: 22353833
[TBL] [Abstract][Full Text] [Related]
30. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
[TBL] [Abstract][Full Text] [Related]
31. Mammography screening and breast cancer mortality in Sweden.
Autier P; Koechlin A; Smans M; Vatten L; Boniol M
J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
[TBL] [Abstract][Full Text] [Related]
32. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
Lund E; Mode N; Waaseth M; Thalabard JC
BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
[TBL] [Abstract][Full Text] [Related]
33. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
[No Abstract] [Full Text] [Related]
35. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
36. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
39. Effect of screening mammography on breast-cancer mortality in Norway.
Kalager M; Zelen M; Langmark F; Adami HO
N Engl J Med; 2010 Sep; 363(13):1203-10. PubMed ID: 20860502
[TBL] [Abstract][Full Text] [Related]
40. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]